Condition: Ventricular Tachycardias · Myocardial Infarction (MI) · Implantable Cardiac Defibrillator · Sponsor: MEDICOVER SP Z O.O.
The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.
This description comes directly from the study's public registry record.
Derejko P Prof. Paweł Derejko, MD, PhD · +48 603338871 · pawel.derejko@medicover.pl
Fabijańska M Project Manager for Clinical Trials in Medicover Hospital · +48 519532444 · magdalena.fabijanska@medicover.pl
Always discuss trial participation with your own doctor first.
| Medicover Hospital | Warsaw, Masovian Voivodeship, Poland | Recruiting |
| Medical University of Warsaw | Warsaw, Masovian Voivodeship, Poland | Recruiting |
| National Institute of Cardiology | Warsaw, Masovian Voivodeship, Poland | Not Yet Recruiting |
| University Hospital No. 1 in Bydgoszcz | Bydgoszcz, Poland | Not Yet Recruiting |
| University Clinical Center based in Gdańsk | Gdansk, Poland | Not Yet Recruiting |
| Independent Public Health Care Facility University Hospital in Krakow | Krakow, Poland | Not Yet Recruiting |
| University Clinical Hospital in Poznań | Poznan, Poland | Not Yet Recruiting |
| University Clinical Hospital No. 2 PUM in Szczecin | Szczecin, Poland | Not Yet Recruiting |
| Grochowski Hospital named after Dr. Rafał Masztak, MD | Warsaw, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07240441